Literature DB >> 6435758

Noradrenaline: a circulating inhibitor of sodium transport.

A Riozzi, A M Heagerty, R F Bing, H Thurston, J D Swales.   

Abstract

Leucocytes were isolated from venous blood of 11 normotensive volunteers with no family history of hypertension and the sodium efflux rate constants determined both alone and in the presence of increasing physiological concentrations of noradrenaline. There was a significant dose dependent reduction of total sodium efflux rate constant due to a reduction in ouabain sensitive sodium pump activity, glycoside insensitive efflux rate constants being unaffected. The magnitude of this effect was similar to the reduction in leucocyte sodium efflux rate constants observed in hypertensive patients (and their normotensive relatives). The noradrenaline induced depression of sodium pump activity was prevented by propranolol in a further seven experiments, suggesting that the effect was mediated by beta adrenoceptors. Catecholamines possibly functioning as circulating inhibitors of sodium transport may contribute to some of the disturbances in membrane electrolyte handling both in essential hypertension in man and in some experimental models of hypertension.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435758      PMCID: PMC1443036          DOI: 10.1136/bmj.289.6451.1025

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  Plasma noradrenaline concentrations in experimental renovascular hypertension in the rat.

Authors:  H J Dargie; S S Franklin; J L Reid
Journal:  Clin Sci Mol Med       Date:  1977-05

2.  Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension.

Authors:  H E de Wardener; G A MacGregor
Journal:  Kidney Int       Date:  1980-07       Impact factor: 10.612

3.  Circulating catecholamine levels in human and experimental hypertension.

Authors:  J de Champlain; L Farley; D Cousineau; M R van Ameringen
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

4.  Leucocyte membrane sodium transport in normotensive populations: dissociation of abnormalities of sodium efflux from raised blood-pressure.

Authors:  A M Heagerty; M Milner; R F Bing; H Thurston; J D Swales
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321

Review 5.  Ion transport in hypertension.

Authors:  J D Swales
Journal:  Biosci Rep       Date:  1982-12       Impact factor: 3.840

6.  Hyperoxaluria in idiopathic calcium stone disease: further evidence of intestinal hyperabsorption of oxalate.

Authors:  M Marangella; B Fruttero; M Bruno; F Linari
Journal:  Clin Sci (Lond)       Date:  1982-10       Impact factor: 6.124

7.  Abnormal leucocyte composition and sodium transport in essential hypertension.

Authors:  R P Edmondson; R D Thomas; P J Hilton; J Patrick; N F Jones
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

8.  Evidence for a circulating sodium transport inhibitor in essential hypertension.

Authors:  L Poston; R B Sewell; S P Wilkinson; P J Richardson; R Williams; E M Clarkson; G A MacGregor; H E de Wardener
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

9.  Hypokalemia from beta2-receptor stimulation by circulating epinephrine.

Authors:  M J Brown; D C Brown; M B Murphy
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

10.  Plasma norepinephrine in essential hypertension. A study of the studies.

Authors:  D S Goldstein
Journal:  Hypertension       Date:  1981 Jan-Feb       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.